We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: No.343, HeZuo Road, West Hi-Tech Zone, 611731, Chengdu, Sichuan, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: T/T
The only product in China that bioequivalence is completely consistent with the original drug. Also, it has been manufactured and marketed in China for some years.
Active ingredient: Enoxaparin Sodium
Description: A colorless to pale yellow clear liquid.
Dosage form: liquid injection
Strength: 0.6ml: 6000AxaIU
Packaging size: 10 ampoules/box, 100 boxes/carton (Can be customized)
Indications:
1. Prevention of venous thromboembolic diseases (prevention of intravenous thrombosis), especially for thrombosis associated with orthopedic or general surgery.
2. Treatment of deep venous thrombosis with or without pulmonary embolism. Clinical symptoms are not serious and does not include pulmonary embolism requiring surgery or thrombolytic therapy.
3. Treatment for pulmonary embolism.
4. Treatment of unstable angina and non-Q-wave myocardial infarction when combined with aspirin.
5. Prevention of thrombogenesis in hemodialysis extracorporeal circulation.
Two years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
